Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 6 of 6 items.

" " XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone…
AlertHealth professional risk communication | 2018-11-08
" " TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis Starting date: September 18, 2018 Posting date: September 18, 2018 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2018-09-18
" " Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing
Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing Starting date: May 1, 2018 Posting date…
AlertHealth professional risk communication | 2018-05-01
" " ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis Starting date: March 16, 2018…
AlertHealth professional risk communication | 2018-03-16
" " Shortage of Erwinase for Injection and Replacement with UK Labelled Stock
Shortage of Erwinase for Injection and Replacement with UK Labelled Stock Starting date: February 27, 2018 Type of communication: Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2018-02-27
" " TECENTRIQ (atezolizumab) - Risk of Myocarditis
TECENTRIQ (atezolizumab) - Risk of Myocarditis Starting date: February 14, 2018 Posting date: February 14, 2018 Type of communication: Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2018-02-14
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.